Meant Health Expands Telehealth Access To FDA-Approved GLP-1 Prescriptions, Including Ozempic

Meant Health, a digital health platform, is expanding telehealth access to Food and Drug Administration (FDA)-approved glucagon-like peptide-1 (GLP-1) medications, including Ozempic. The platform connects consumers with United States-licensed health care professionals for evaluations, prescriptions, and ongoing care coaching. Consumers complete an intake questionnaire covering their health history, current medications, and treatment goals. A licensed health care professional reviews the information and determines, on a case-by-case basis, whether GLP-1 treatment is appropriate.

Ozempic is FDA approved to treat type 2 diabetes. Its use for weight management is off-label and remains at . . .